Patents by Inventor Feng-te Chou

Feng-te Chou has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Aziridinyl quinone antitumor agents
    Patent number: 4704384
    Abstract: The use of aziridinyl quinones as antitumor agents is disclosed. A compound which has been found to be particularly effective is the compound 2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone. Treatment is described in connection with various forms of leukemia, for example, as well as B16 melanoma, Lewis lung carcinoma, and the ependymoblastoma brain tumor system.
    Type: Grant
    Filed: December 18, 1981
    Date of Patent: November 3, 1987
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: John S. Driscoll, A. Hameed Khan, Feng-Te Chou
  • Aziridinyl quinone antitumor agents
    Patent number: 4233215
    Abstract: The use of aziridinyl quinones as antitumor agents against transplanted tumors in mice is disclosed. A compound which has been found to be particularly effective is the compound 2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone. Treatment is described in connection with several transplanted mouse tumor test systems including various forms of leukemia, for example, as well as B16 melanoma, Lewis lung carcinoma, and the ependymoblastoma brain tumor system.
    Type: Grant
    Filed: October 24, 1978
    Date of Patent: November 11, 1980
    Assignee: United States of America
    Inventors: John S. Driscoll, A. Hameed Khan, Feng-Te Chou
  • Aziridinyl quinone anti-transplanted tumor agents
    Patent number: 4146622
    Abstract: The use of aziridinyl quinones as antitumor agents against transplanted tumors in mice is disclosed. A compound which has been found to be particularly effective is the compound 2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone. Treatment is described in connection with several transplanted mouse tumor test systems including various forms of leukemia, for example, as well as B16 melanoma, Lewis lung carcinoma, and the ependymoblastoma brain tumor system.
    Type: Grant
    Filed: January 12, 1977
    Date of Patent: March 27, 1979
    Assignee: The Government of the United States
    Inventors: John S. Driscoll, A. Hameed Khan, Feng-te Chou